Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review

C. A. Riemer, R. A. el-Azhary, K. L. Wu, J. J. Strand, Julia Lehman

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Calciphylaxis is associated with significant morbidity and mortality. Palliative care (PC) is a subspecialty that treats the pain and stress of serious illness. To assess whether the role of quality of life (QoL) indices, patient-reported outcome measures and PC have been studied in patients with calciphylaxis, we performed a systematic literature review. Several databases were searched from inception to October 2016 according to modified Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. We searched for papers on calciphylaxis that mentioned the symptoms and supportive needs of patients, QoL or outcome measures to report symptom severity, and the involvement of PC. Twelve papers met the inclusion criteria. Reported patient symptoms included pain, skin lesion resolution and pruritus, with the first being the most frequently reported. Four papers measured pain using a previously verified patient-reported outcome measure, including the Visual Analogue Scale. One paper used a verified QoL measure, the Dermatology Quality of Life Index. No tool was used consistently. Eight papers reported the use of hospice care or PC in the treatment of calciphylaxis. No outcome measure was used to prompt PC involvement. Overall, QoL indices, patient-reported outcome measures and PC are underreported in the treatment of calciphylaxis. PC may be a resource to assist in symptom management and adaptive coping strategies for patients from the onset of disease.

Original languageEnglish (US)
Pages (from-to)1510-1518
Number of pages9
JournalBritish Journal of Dermatology
Volume177
Issue number6
DOIs
StatePublished - Jan 1 2017

Fingerprint

Calciphylaxis
Palliative Care
Quality of Life
Pain
Outcome Assessment (Health Care)
Hospice Care
Pruritus
Dermatology
Patient Reported Outcome Measures
Visual Analog Scale
Meta-Analysis
Databases
Morbidity
Skin
Mortality

ASJC Scopus subject areas

  • Dermatology

Cite this

Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis : a systematic review. / Riemer, C. A.; el-Azhary, R. A.; Wu, K. L.; Strand, J. J.; Lehman, Julia.

In: British Journal of Dermatology, Vol. 177, No. 6, 01.01.2017, p. 1510-1518.

Research output: Contribution to journalReview article

@article{ad02081aed0c42db873dbf2c1f2133b8,
title = "Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review",
abstract = "Calciphylaxis is associated with significant morbidity and mortality. Palliative care (PC) is a subspecialty that treats the pain and stress of serious illness. To assess whether the role of quality of life (QoL) indices, patient-reported outcome measures and PC have been studied in patients with calciphylaxis, we performed a systematic literature review. Several databases were searched from inception to October 2016 according to modified Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. We searched for papers on calciphylaxis that mentioned the symptoms and supportive needs of patients, QoL or outcome measures to report symptom severity, and the involvement of PC. Twelve papers met the inclusion criteria. Reported patient symptoms included pain, skin lesion resolution and pruritus, with the first being the most frequently reported. Four papers measured pain using a previously verified patient-reported outcome measure, including the Visual Analogue Scale. One paper used a verified QoL measure, the Dermatology Quality of Life Index. No tool was used consistently. Eight papers reported the use of hospice care or PC in the treatment of calciphylaxis. No outcome measure was used to prompt PC involvement. Overall, QoL indices, patient-reported outcome measures and PC are underreported in the treatment of calciphylaxis. PC may be a resource to assist in symptom management and adaptive coping strategies for patients from the onset of disease.",
author = "Riemer, {C. A.} and el-Azhary, {R. A.} and Wu, {K. L.} and Strand, {J. J.} and Julia Lehman",
year = "2017",
month = "1",
day = "1",
doi = "10.1111/bjd.15702",
language = "English (US)",
volume = "177",
pages = "1510--1518",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis

T2 - a systematic review

AU - Riemer, C. A.

AU - el-Azhary, R. A.

AU - Wu, K. L.

AU - Strand, J. J.

AU - Lehman, Julia

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Calciphylaxis is associated with significant morbidity and mortality. Palliative care (PC) is a subspecialty that treats the pain and stress of serious illness. To assess whether the role of quality of life (QoL) indices, patient-reported outcome measures and PC have been studied in patients with calciphylaxis, we performed a systematic literature review. Several databases were searched from inception to October 2016 according to modified Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. We searched for papers on calciphylaxis that mentioned the symptoms and supportive needs of patients, QoL or outcome measures to report symptom severity, and the involvement of PC. Twelve papers met the inclusion criteria. Reported patient symptoms included pain, skin lesion resolution and pruritus, with the first being the most frequently reported. Four papers measured pain using a previously verified patient-reported outcome measure, including the Visual Analogue Scale. One paper used a verified QoL measure, the Dermatology Quality of Life Index. No tool was used consistently. Eight papers reported the use of hospice care or PC in the treatment of calciphylaxis. No outcome measure was used to prompt PC involvement. Overall, QoL indices, patient-reported outcome measures and PC are underreported in the treatment of calciphylaxis. PC may be a resource to assist in symptom management and adaptive coping strategies for patients from the onset of disease.

AB - Calciphylaxis is associated with significant morbidity and mortality. Palliative care (PC) is a subspecialty that treats the pain and stress of serious illness. To assess whether the role of quality of life (QoL) indices, patient-reported outcome measures and PC have been studied in patients with calciphylaxis, we performed a systematic literature review. Several databases were searched from inception to October 2016 according to modified Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. We searched for papers on calciphylaxis that mentioned the symptoms and supportive needs of patients, QoL or outcome measures to report symptom severity, and the involvement of PC. Twelve papers met the inclusion criteria. Reported patient symptoms included pain, skin lesion resolution and pruritus, with the first being the most frequently reported. Four papers measured pain using a previously verified patient-reported outcome measure, including the Visual Analogue Scale. One paper used a verified QoL measure, the Dermatology Quality of Life Index. No tool was used consistently. Eight papers reported the use of hospice care or PC in the treatment of calciphylaxis. No outcome measure was used to prompt PC involvement. Overall, QoL indices, patient-reported outcome measures and PC are underreported in the treatment of calciphylaxis. PC may be a resource to assist in symptom management and adaptive coping strategies for patients from the onset of disease.

UR - http://www.scopus.com/inward/record.url?scp=85034221743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034221743&partnerID=8YFLogxK

U2 - 10.1111/bjd.15702

DO - 10.1111/bjd.15702

M3 - Review article

C2 - 28580642

AN - SCOPUS:85034221743

VL - 177

SP - 1510

EP - 1518

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 6

ER -